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Optimal Control of SonoVue Microbubbles to
Estimate Hydrostatic Pressure
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Jason L. Raymond, Member, IEEE, Mark J. Monaghan, Daniel Fuster, Flemming Forsberg, Senior Member, IEEE,
Robert J. Eckersley, Senior Member, IEEE, and Pablo Lamata
Abstract—The measurement of cardiac and aortic pressures
enable diagnostic insight into cardiac contractility and stiffness.
However, these pressures are currently assessed invasively using
pressure catheters. It may be possible to estimate these pressures
less invasively by applying microbubble ultrasound contrast
agents as pressure sensors. The aim of this study was to inves-
tigate the subharmonic response of the microbubble ultrasound
contrast agent SonoVue (Bracco Spa, Milan, Italy) at physiolog-
ical pressures using a static pressure phantom. A commercially
available cell culture cassette with Luer connections was used as
a static pressure chamber. SonoVue was added to the phantom,
and radiofrequency data were recorded on the ULtrasound
Advanced Open Platform (ULA-OP). The mean subharmonic
amplitude over a 40% bandwidth was extracted at 0–200 mmHg
hydrostatic pressures, across 1.7–7.0 MHz transmit frequencies
and 3.5–100% maximum scanner acoustic output. The Rayleigh-
Plesset equation for single bubble oscillations and additional
hysteresis experiments were used to provide insight into the
mechanisms underlying the subharmonic-pressure response of
SonoVue. The subharmonic amplitude of SonoVue increased
with hydrostatic pressure up to 50 mmHg across all transmit
frequencies, and decreased thereafter. A decreasing microbubble
surface tension may drive the initial increase in the subharmonic
amplitude of SonoVue with hydrostatic pressure, while shell
buckling and microbubble destruction may contribute to the
subsequent decrease above 125 mmHg pressure. In conclusion,
a practical operating regime that may be applied to estimate
cardiac and aortic blood pressures from the subharmonic signal
of SonoVue has been identified.
Index Terms—ultrasound contrast agents, subharmonic imag-
ing, hydrostatic pressure.
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I. INTRODUCTION
M ICROBUBBLE based ultrasound contrast agents arecurrently used in the clinic to complement stan-
dard B-mode imaging across multiple organs and sys-
tems in the human body, including the heart, breast and
liver [1]–[4]. In the heart, the commercially available contrast
agents SonoVue/Lumason (Bracco Spa, Milan, Italy), Lumin-
ity/Definity (Lantheus Medical Imaging Inc., N. Billerica,
MA, USA) and Optison (GE Healthcare, Princeton, NJ, USA)
may be applied to assess left ventricular function, structural
left ventricular abnormalities and myocardial perfusion [2],
[3]. In addition, these microbubbles have a promising new
application as pressure sensors [5], [6], which would enable
minimally invasive estimations of the cardiac and large artery
pressures underpinning diagnostic information on cardiac con-
tractility and stiffness [7]–[9]. Successful implementation of
microbubble based cardiac pressures would provide a safer and
more cost-effective alternative to the current clinical method
requiring invasive cardiac catheterization [8], [9].
Using single element transducers, the ultrasound contrast
agents Levovist, Optison, Definity, ZFX and Sonazoid have
been found to generate a subharmonic signal that is linearly
and negatively correlated to static hydrostatic pressures from
0–186 mmHg [10]. This phenomenon may be due to changes
in bubble surface tension and shell buckling [11], [12], and is
additionally affected by ultrasound settings such as transmit
frequency, pulse length and acoustic pressure. As acoustic
pressure increases, the subharmonic signal of ultrasound con-
trast agents can be delineated into three distinct phases: (i)
occurrence, (ii) growth and (iii) saturation (for an example, see
Fig. 3) [13], [14]. In the occurrence and saturation phases, the
subharmonic amplitude is stable despite increases in acoustic
pressure. In contrast, the growth phase is characterized by an
increase in subharmonic amplitude with acoustic pressure. An
acoustic pressure within the growth phase has been shown
to be necessary to elicit a strong negative linear relationship
between the subharmonic amplitude of ultrasound contrast
agents and hydrostatic pressure [6], [13].
Among the commercially-available ultrasound contrast
agents, Sonazoid has been investigated the most extensively
due to its greatest sensitivity to hydrostatic pressure following
the study by Halldorsdottir and colleagues [10]. However,
Sonazoid is currently not approved nor marketed in Europe
[15]. A potential alternative to Sonazoid is the ultrasound
contrast agent SonoVue marketed by Bracco Spa, which is
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widely used in Europe [3]. To our knowledge, there have
been three investigations of SonoVue as a potential pressure
sensor [16]–[18], and none of these have been done by the
research group spearheading current efforts with Sonazoid.
The first study was by Andersen and Jensen [16], who in
fact examined the ratio of the subharmonic to fundamental
components, instead of the subharmonic as described by
Halldorsdottir and colleagues [10]. The second study by Sun
and colleagues [18] found an increase in the subharmonic
signal with hydrostatic pressure when excited by a 1.33 MHz
ultrasound pulse at an acoustic pressure of 300 kPa, but a
decrease when excited by a 4 MHz pulse at a similar acoustic
pressure (300 kPa). In contrast, the third study by Li and
colleagues (which was published in 2018 while data collection
for this current study was ongoing) [17] reported a decrease
in the subharmonic signal with hydrostatic pressure when
excited by a 1.33 MHz ultrasound pulse at an acoustic pressure
of 350 kPa, but an increase from 0–50 mmHg hydrostatic
pressure at 4 MHz and the same acoustic pressure (350 kPa),
followed by a decrease from 50–180 mmHg. At 4 MHz
and 450–500 kPa acoustic pressures, Li and colleagues [17]
found a decrease in the subharmonic signal with hydrostatic
pressure, as would be expected from previous work with other
ultrasound contrast agents [10]. Of specific relevance to the
investigation of SonoVue as a potential pressure sensor is the
work by Frinking and colleagues that examined SonoVue-like
microbubbles from Bracco Research [11] — they found an
increase in the subharmonic signal of SonoVue-like microbub-
bles to hydrostatic pressure at 4 MHz and 50 kPa acoustic
pressure, no change in the subharmonic signal at the same
transmit frequency (4 MHz) and 200 kPa acoustic pressure, but
a decrease at 400 kPa acoustic pressure. The conflicting data in
the literature mean that the subharmonic response of SonoVue
to hydrostatic pressure has not been established and is still
unclear. Building upon the extensive work led by Forsberg and
colleagues towards developing Sonazoid as a pressure sensor,
it is probable that an experimental protocol similar to that
being used with Sonazoid may help clarify the subharmonic
response of SonoVue to hydrostatic pressure.
The aim of this study was to investigate the subharmonic
response of the ultrasound contrast agent SonoVue at phys-
iological pressures using a static pressure phantom. We hy-
pothesized that the subharmonic signal of SonoVue would
exhibit (i) a growth phase with increasing acoustic pres-
sures, and (ii) a negative linear relationship with hydrostatic
pressure at an acoustic pressure within this growth phase.
The Rayleigh-Plesset equation for single bubble oscillations,
combined with an effective bubble surface tension [19], and
additional hysteresis experiments were used to provide in-
sight into the mechanisms underlying the empirically-observed
subharmonic-pressure response. Part of this work, limited to
the data at transmit frequency 5 MHz, was first presented at
the 2017 IEEE International Ultrasonics Symposium [20].
II. MATERIALS AND METHODS
A. Static pressure chamber
A phantom capable of maintaining 0–200 mmHg static hy-
drostatic pressures was developed using a cell culture cassette
with Luer connections (CLINIcell 25, 175 µm membrane,
10 mL volume, 6.8 cm × 3.9 cm × 3.7 mm, Mabio In-
ternational, Tourcoing, France), and submerged in a water
bath (Fig. 1). Luer connections ensured that the CLINIcell
chamber was air-tight to maintain stable hydrostatic pressures.
A similar cell culture cassette albeit with a thinner membrane
(50 µm membrane) has been recently demonstrated as a
viable chamber for microbubble studies [21]. The ultrasound
transducer was positioned at a 45◦ angle relative to the cell
culture cassette [22]. This enabled a clear region of interest
with minimal backscatter from the cassette windows, and
concomitantly increased the effective depth of the pressure
chamber on the ultrasound image to 5.2 mm. A 1.5 mm
magnetic stirrer was inserted into the cassette to maintain a ho-
mogenous concentration of microbubbles within the pressure
chamber.
Acoustic
absorbers
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Tr
an
sd
uc
er
ULA-OP + MATLAB
Tubing with Luer inlet + syringe
Tubing with Luer outlet
(for waste)
Pressure
sensor
Pressure meter
with digital display
Water
bath
CLIN
Icell
Fig. 1. Schematic representation of the static pressure phantom. The CLINI-
cell was submerged in a water bath with layers of acoustically-absorbent foam
in front of and behind it. The transducer was positioned at a 45◦ angle relative
to the window of the CLINIcell. SonoVue was added to the CLINIcell with
a syringe, via a Luer stopcock.
High pressure PVC tubing was secured to the cassette via
the two Luer ports (900 PSI, Cole-Parmer, Cambridgeshire,
UK), and led out of the water bath to entry and exit Luer
stopcocks for administering microbubble solution. Prior to the
exit stopcock, a pressure sensor (PRESS-S-000 sensor, Pen-
doTech, Princeton, NJ, USA) was connected and positioned
outside the water bath at the same height as the middle of
the submerged cassette. The pressure sensor was connected
to a digital pressure meter (INFCS-112B meter, Newport
Electronics, Inc., Santa Ana, CA, USA) calibrated at 0 mmHg
(ambient pressure) and 147 mmHg using a water column (2 m
water column).
B. Attenuation and insertion loss
A 12-mm layer of open-cell melamine foam (Basotect,
BASF, Ludwigshafen, Germany) was positioned in front of the
cassette to create an attenuating layer between the ultrasound
transducer and the microbubbles. To measure the attenuation
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resulting from this foam and the insertion loss through one
window of the cell culture cassette, a pair of broadband trans-
ducers (Panametrics V311, 12.7 mm diameter, 59 mm focal
length, 10 MHz center frequency; Panametrics V310, 6.35 mm
diameter, 5 MHz center frequency; Olympus NDT, Waltham,
MA, USA) were used to acquire the through-transmission
spectrum using a broadband substitution technique [23]. Mea-
surements were conducted in an 8 L acrylic tank (45 × 12
× 15 cm) filled with distilled water. An ultrasound pulser-
receiver (DPR300, JSR Ultrasonics, Pittsford, NY, USA) was
used to generate the excitation pulse and amplify the received
signal (20–50 dB gain). Received waveforms were averaged
(typically 64 traces/acquisition), digitized (LT264, LeCroy,
Chestnut Ridge, NY, USA), and transferred to a computer
for analysis using MATLAB (The MathWorks, Inc., Natick,
MA, USA). Attenuation through the open-cell melamine foam
and insertion loss through one window of the CLINIcell were
used to calculate total acoustic signal loss, and to estimate
the incident acoustic pressure within the cassette chamber
(acoustic pressure in a water bath × 10−total signal loss/20).
All tables and figures show peak-negative acoustic pressure
corrected for signal loss, unless stated otherwise.
Layers of acoustically-absorbent open-cell foam were ad-
ditionally positioned behind the cassette to reduce artifacts
created due to reflections and scattering beyond the cassette
chamber.
C. Experiments with SonoVue at 0–200 mmHg hydrostatic
pressures
SonoVue was reconstituted according to manufacturer’s
instructions, and diluted in gas-equilibrated water to yield the
typical concentration used in the clinic (0.4 µL/mL water).
With the exit port open and the magnetic stirrer spinning in the
cassette chamber, approximately 25 mL of diluted microbubble
solution was added to the static pressure phantom (≈0.5 mL/s).
The exit port was then closed and hydrostatic pressure was
increased by adding more microbubble solution.
Radiofrequency data were recorded across the bandwidth of
a linear and a phased array ultrasound transducer (bandwidth
3–7 MHz, LA332E Marzo 2014 and bandwidth 1.2–2.1 MHz,
PA230, respectively; Esaote, Genoa, Italy) on the ULtrasound
Advanced Open Platform (ULA-OP, MSD Lab, University of
Florence, Florence, Italy). These transducers were used in this
study to encompass vascular and cardiac imaging.
Pulse-inversion sequences and long transmit pulses were
used to enhance the non-linear microbubble signal [18], [24].
A longer transmit pulse has been found to enhance the sub-
harmonic signal-to-noise ratio, and reduce the transient effect
of pulse length due to the growth and decay at the beginning
and end of each ultrasound pulse on the subharmonic signal
[18], [24]. Therefore, pulse length was chosen to maximize the
number of cycles per pulse, while not exceeding the 5.2 mm
effective chamber depth (with a 45◦ angle of insonation). 16-
cycle pulses were used at transmit frequencies 5–7 MHz, 12
cycle pulses at 4 MHz, 10 cycle pulses at 3 MHz, 7 cycle
pulses at 2.1 MHz, and 5 cycle pulses at 1.7 MHz. Pulse
length at transmit frequency 5 MHz with 16-cycle pulses was
4.14 mm (standard deviation 0.02 mm, n = 3, 82% maximum
scanner acoustic output). The maximum mechanical index on
the linear transducer was 0.52 at transmit frequency 6 MHz
with 16-cycle pulses, and that on the phased array transducer
was 0.41 at transmit frequency 2.1 MHz with 7 cycle pulses,
as measured with a 0.5 mm hydrophone (SN1832, Precision
Acoustics Ltd, Dorchester, UK) in a water bath.
Data were first recorded at ambient hydrostatic pressure (0
mmHg) from 3.5–100% maximum scanner acoustic output
(n = 40, equally spaced on a logarithmic scale; 9 min per
dataset of incremental acoustic outputs) [13] — to determine
the acoustic pressure range that elicited the growth phase
response of SonoVue. Subsequently, data were recorded across
scanner acoustic output levels corresponding to the growth
phase (n = 20; 4 min per dataset).
Experiments were performed from 200 to 0 mmHg hydro-
static pressures in 25 mmHg decrements, and then repeated.
The microbubble solution in the phantom was replenished
after each set of acoustic output levels. Experiments at in-
dividual hydrostatic pressure levels were further repeated if
no crossover was observed between the first two sets (i.e.,
if one set of data points was consistently higher than the
other set within the growth phase). The erroneous dataset was
determined based on its large variation from the other two
runs that had intersecting growth phases, attributed to human
error in replenishing the microbubble solution or noise [25],
and discarded. Across the transmit frequencies investigated,
additional runs were recorded at 2–6 pressure levels (out of
9) to obtain intersecting growth phases (i.e., 1.7 MHz: 0, 50,
75, 100, 125 and 150 mmHg; 2.1 MHz: 175 and 200 mmHg;
3 MHz: 0, 25, 100, 125, 150 and 175 mmHg; 4 MHz: 0, 25,
150, 175 and 200 mmHg; 5 MHz: 0, 25, 100 and 175 mmHg;
6 MHz: 0, 25, 50, 150, 175 and 200 mmHg; 7 MHz: 0, 175
and 200 mmHg). Noisy subharmonic data is common, and can
be mitigated in vivo by applying a median filter on a larger
number of frames [26]. All experiments were performed at
room temperature (≈21◦C), and were completed within 7 h
of microbubble reconstitution. Crossover of the data between
repeats indicated that the subharmonic signal of SonoVue was
stable across this period.
D. Extracting and analyzing the subharmonic signal
The mean signal amplitude over a 40% bandwidth around
the nominal subharmonic frequency (i.e., transmit frequency
f0/2) was extracted offline using MATLAB [26]. A zero-
phase digital filter was applied with a finite impulse response
(FIR) band-pass filter to isolate the signal over the subhar-
monic bandwidth. In experiments with the linear transducer,
a 15.5 × 3 mm region of interest was defined based on the
B-mode image at the center frequency of 5 MHz with 16-
cycle pulses (Fig. 2). In experiments with the phased array
transducer, a sector region of interest with 3 mm depth was
defined from the B-mode image at transmit frequency 2.1 MHz
with 7 cycle pulses. The average subharmonic amplitude was
calculated as the mean amplitude across three frames of the
region of interest (i.e., 3 frames × 64 lines/frame).
Linear regressions between subharmonic amplitude and hy-
drostatic pressure were performed at each acoustic output level
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-55 kPa -121 kPa -285 kPa
Fig. 2. 2D images of the subharmonic signal at (A) 55 kPa, (B) 121 kPa,
and (C) 285 kPa peak-negative acoustic pressures, illustrating a greater am-
plitude (dB) with increasing peak-negative acoustic pressure. In this example,
hydrostatic pressure was maintained at 75 mmHg, and data were recorded
at transmit frequency 4 MHz with 12 cycle pulses. The region of interest is
demarcated by the black rectangular border.
to identify the maximum sensitivity of SonoVue to changes in
hydrostatic pressure. Mean error was calculated as the mean
absolute difference between the data and the regression line.
E. Using the Rayleigh-Plesset equation to investigate the
subharmonic-pressure relationship of SonoVue
To gain first insights into the mechanisms underlying the
subharmonic-pressure relationship of SonoVue, we used a
classical model for single bubble oscillations described by
the Rayleigh-Plesset equation and assumed an adiabatic gas
response. The Peclet number for a two-micron air bubble
at 1 MHz is 120, and therefore the adiabatic assumption
(Pe  1) is verified [27]. This provided the amplitude of
bubble oscillation as a function of hydrostatic pressure when
the bubble is excited with a pure sinusoidal wave of known fre-
quency f and fixed peak-to-peak acoustic pressure of 150 kPa.
The equilibrium bubble radius R0 at a given pressure p was
obtained by assuming that the amount of gas inside the bubble
remains constant:
R30
(
p+
2σ
R0
)
= Cref (1)
where Cref is a constant obtained from the reference radius
Rref measured at the reference pressure. Rref = 2 µm, using
the typical modal radius of SonoVue at reference pressure [28].
The amplitude of SonoVue bubble oscillations is addition-
ally affected by buckling of its phospholipid monolayer [19],
[28]. As hydrostatic pressure increases, bubble radius de-
creases and buckling occurs below a critical radius, which
is dependent on the number of phospholipid molecules sur-
rounding the bubble. Effective surface tension σ of the lipid
monolayer ranges from 0.07 N/m in the elastic state for
air/water systems, to 0 N/m in the buckled state (Eq. 1). A
parametric study was performed to investigate the influence
of surface tension on the amplitude of bubble oscillations.
We then used the predicted oscillation amplitude from the
single bubble model to estimate reflected sound as a function
of hydrostatic pressure. In the weakly non-linear regime, it is
reasonable to assume that the intensity of reflected sound is
proportional to the intensity of non-linearity [29] and inversely
proportional to the void fraction [30]. These parameters are
represented in Equation 2 as bubble oscillation amplitude and
equilibrium pressure (p0), respectively. If we adjust the model
using the signal intensity at the reference pressure for air water
bubbles, the predicted amplitude A in dB across 0–200 mmHg
equilibrium pressures p0 is:
A = 27 + 20 log
(
∆R0
∆Rref
pref
p0
)
(2)
F. Hysteresis experiments to investigate the irreversible impact
of hydrostatic pressure on SonoVue
SonoVue was added to the static pressure phantom fol-
lowing the experimental protocol in Section II-C. A transmit
frequency of 5 MHz with 16-cycle pulses was used for this
set of experiments. Similar to the experiments in Section II-C,
radiofrequency data were first recorded at ambient pressure
(0 mmHg) to determine the range of scanner acoustic output
levels corresponding to the growth phase (n = 40).
To investigate the irreversible impact of hydrostatic pressure
on SonoVue, the microbubble solution in the phantom was first
maintained at 200–0 mmHg without insonation. The pressure
chamber was then returned to 0 mmHg, and data were recorded
at scanner acoustic output levels corresponding to the growth
phase (n = 20). SonoVue solution in the phantom was replen-
ished after each set of acoustic output levels. Experiments were
performed in 25 mmHg decrements. Three sets of data were
recorded for each hydrostatic pressure level, and experiments
were completed within 4.5 h of microbubble reconstitution.
III. RESULTS
A. Acoustic signal loss before reaching the microbubbles
At the 45◦ angle of insonation used in this study, total
attenuation through the foam and single cassette window
ranged from 4.6–16.2 dB across 1.7–7.0 MHz transmit fre-
quencies (Tables I–II). The insertion loss across 0–50◦ angles
of insonation are reported in the Appendix.
TABLE I
ATTENUATION THROUGH OPEN-CELL MELAMINE FOAM (BASOTECT,
BASF, GERMANY) ACROSS 1–7 MHZ TRANSMIT FREQUENCIES. VALUES
ARE MEAN (STANDARD DEVIATION) OF TWO MEASUREMENTS.
Frequency (MHz) Attenuation (dB/cm)
1.0 0.89 (0.44)
2.0 1.00 (0.49)
3.0 1.12 (0.61)
4.0 1.35 (0.66)
5.0 1.75 (0.60)
6.0 2.15 (0.55)
7.0 2.51 (0.50)
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TABLE II
INSERTION LOSS THROUGH ONE WINDOW OF THE CLINICELL CHAMBER
AT A 45◦ ANGLE OF INSONATION, ACROSS 1–7 MHZ TRANSMIT
FREQUENCIES. VALUES ARE MEAN (STANDARD DEVIATION) OF FOUR
MEASUREMENTS.
Frequency (MHz) Insertion loss (dB)
1.0 0.92 (0.05)
1.5 2.04 (0.06)
2.0 4.36 (0.08)
2.5 10.45 (0.28)
3.0 14.30 (0.39)
3.5 4.34 (0.11)
4.0 2.63 (0.05)
4.5 2.72 (0.09)
5.0 3.22 (0.17)
5.5 3.64 (0.14)
6.0 4.25 (0.03)
6.5 7.23 (0.16)
7.0 10.50 (0.57)
B. Occurrence, growth and saturation phases of SonoVue with
increasing acoustic pressure
SonoVue generated subharmonic signals that followed the
characteristic occurrence, growth and saturation phases previ-
ously observed in microbubble ultrasound contrast agents [13]
(representative example in Fig. 3). The acoustic pressures cor-
responding to these phases varied across transmit frequencies,
with the growth phase occurring between 50–250 kPa peak-
negative pressure.
Occurrence
Growth
Saturation
Fig. 3. Mean subharmonic amplitude of SonoVue at ambient hydrostatic
pressure (0 mmHg) across the full range of scanner acoustic pressures at
transmit frequency 4 MHz (n = 2). SD: 1 standard deviation.
C. Ascending and descending phases of the subharmonic
amplitude of SonoVue with hydrostatic pressure
From 0 to 50 mmHg hydrostatic pressure, the subharmonic
signal of SonoVue increased for all transmit frequencies
investigated in this study (1.7–7.0 MHz; Fig. 4). Between
50–75 mmHg hydrostatic pressure, the subharmonic signal
further increased for most transmit frequencies except at 1.7
and 3.0 MHz, which corresponded to the lowest transmit
frequencies investigated for both the linear and phased array
transducers. For these transmit frequencies, the subharmonic
signal plateaued between 50–75 mmHg.
Above 75 mmHg, the subharmonic signal decreased as
hydrostatic pressure increased for transmit frequencies 1.7–
3.0 MHz. For transmit frequencies 4.0–7.0 MHz, however, the
subharmonic signal plateaued between 75–125 mmHg hydro-
static pressure, and only decreased as hydrostatic pressures
were increased above 125 mmHg. The maximum sensitiv-
ity of the subharmonic-pressure relationship for each trans-
mit configuration was identified for 0–75 mmHg and 125–
200 mmHg hydrostatic pressures separately, and summarized
in Tables III–IV, and Fig. 5.
TABLE III
MAXIMUM SENSITIVITY OF THE SUBHARMONIC AMPLITUDE OF
SONOVUE TO 0–75 MMHG HYDROSTATIC PRESSURE ACROSS
1.7–7.0 MHZ TRANSMIT FREQUENCIES
Linear regression
results
1.7
MHz
2.1
MHz
3.0
MHz
4.0
MHz
5.0
MHz
6.0
MHz
7.0
MHz
Maximum
sensitivity
(dB/mmHg)
0.16 0.15 0.13 0.15 0.13 0.07 0.09
Mean error
(mmHg)
13.9 4.4 7.6 2.0 1.4 5.6 9.6
Peak-negative
pressure (kPa)
126 155 53 121 141 153 140
Mechanical index 0.16 0.24 0.20 0.11 0.13 0.16 0.29
Adjusted r2 0.677 0.957 0.894 0.992 0.995 0.938 0.820
p 0.007 <0.001 <0.001 <0.001 <0.001 <0.001 0.001
TABLE IV
MAXIMUM SENSITIVITY OF THE SUBHARMONIC AMPLITUDE OF
SONOVUE TO 125–200 MMHG HYDROSTATIC PRESSURE ACROSS
1.7–7.0 MHZ TRANSMIT FREQUENCIES
Linear regression
results
1.7
MHz
2.1
MHz
3.0
MHz
4.0
MHz
5.0
MHz
6.0
MHz
7.0
MHz
Maximum
sensitivity
(dB/mmHg)
−0.09 −0.09 −0.07 −0.14 −0.16 −0.13 −0.05
Mean error
(mmHg)
9.2 7.1 10.9 2.6 3.6 6.9 8.5
Peak-negative
pressure (kPa)
233 155 78 101 131 273 191
Mechanical index 0.30 0.24 0.29 0.09 0.12 0.28 0.40
Adjusted r2 0.871 0.911 0.811 0.986 0.974 0.910 0.864
p <0.001 <0.001 0.001 <0.001 <0.001 <0.001 <0.001
D. Effects of hydrostatic pressure and surface tension using
the Rayleigh-Plesset equation
At a constant surface tension (σ = 0.07 N/m), the simu-
lations revealed a decrease in subharmonic amplitude with
increasing hydrostatic pressure (Fig. 6A). In contrast, at a
constant hydrostatic pressure (p = 0 mmHg), subharmonic
amplitude increased with decreasing surface tension (Fig. 6B).
The predicted subharmonic amplitude in dB as a function of
hydrostatic pressure and surface tension is shown in Fig. 7.
E. Effects of prior exposure to 0–200 mmHg hydrostatic
pressures on the subharmonic signal of SonoVue
The subharmonic amplitude of SonoVue was lower after
exposure to 150–200 mmHg hydrostatic pressures, but not
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Fig. 4. Mean subharmonic amplitude of SonoVue at 0–200 mmHg hydrostatic
pressures, across transmit frequencies 1.7 and 2.1 MHz with the phased array
transducer, and 3.0–7.0 MHz with the linear transducer (n = 2). The left
column shows the ascending phase of the subharmonic-pressure relationship,
while the right column shows the descending phase. Data at the plateau phase
are repeated in both columns for reference. Translucent shading indicates 1
standard deviation around the mean. The horizontal axis differs between rows
for clarity of the individual plots.
Fig. 5. Subharmonic amplitude of SonoVue from 0–200 mmHg hydrostatic
pressure at transmit frequency 4 MHz and 121 kPa peak-negative acoustic
pressure (n = 2). Sensitivity of the subharmonic signal to 0–75 mmHg
hydrostatic pressure was 0.15 dB/mmHg (r2 = 0.99; p < 0.001).
(A) (B)
subharmonic
Fig. 6. Amplitude of bubble oscillation using the Rayleigh-Plesset equation
with 150 kPa peak-to-peak acoustic pressure. (A) Simulation results at 0, 100
and 200 mmHg hydrostatic pressures. (B) Simulation results at and below the
surface tension corresponding to air/water systems (0–0.07 N/m).
Fig. 7. Predicted subharmonic amplitude across 0–200 mmHg hydrostatic
pressures and 0.00–0.07 N/m bubble surface tension, derived using the
Rayleigh-Plesset equation with a bubble radius of 2 µm. The blue line
shows a possible increase of the subharmonic signal with decreasing surface
tension; the red line marks the decrease in subharmonic signal with increasing
hydrostatic pressure at zero surface tension.
following exposure to 0–125 mmHg (Fig. 8). The greatest
decrease in subharmonic amplitude between exposures to 125
and 200 mmHg hydrostatic pressures was 3.2 dB, which
occurred at 181 kPa peak-negative acoustic pressure (26.6%
maximum scanner acoustic output).
IV. DISCUSSION
In this study, we investigated the subharmonic response of
the microbubble ultrasound contrast agent SonoVue at 0–200
mmHg hydrostatic pressures using a static pressure phantom.
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Fig. 8. Mean subharmonic amplitude of SonoVue at ambient hydrostatic
pressure (0 mmHg), after 1 min of exposure to higher pressures (n = 3;
standard deviations omitted for clarity). Data recorded with transmit frequency
5 MHz and 16-cycle pulses. Horizontal axis: water bath acoustic pressures
corrected for 6.19 dB signal loss through the melamine foam and cassette
window.
We developed a new phantom from commercially available
components, an acquisition protocol to record radiofrequency
data at incremental acoustic output levels, and a signal pro-
cessing toolbox to extract the subharmonic amplitude from the
received signal. The subharmonic signal of SonoVue increased
from 0–50 mmHg hydrostatic pressure across 1.7–7.0 MHz
transmit frequencies, and decreased from 125–200 mmHg.
Decreasing surface tension may explain the increase in subhar-
monic signal from 0–50 mmHg pressure, while shell buckling
and bubble destruction likely contribute to the decrease in
subharmonic signal from 125–200 mmHg.
A. Optimal transmit frequency to use the subharmonic signal
of SonoVue to estimate hydrostatic pressure
Across the transmit frequencies investigated, 4.0 MHz
elicited the best subharmonic sensitivity for assessing hydro-
static pressures up to 75 mmHg (0.15 dB/mmHg). Comparable
sensitivities to hydrostatic pressure were found for transmit
frequencies 1.7–3.0 MHz, but the decrease in subharmonic
signal from 75–125 mmHg would result in non-unique values
that may be incorrectly interpreted when used to estimate
pressures in vivo. This is not a concern at transmit frequency
4.0 MHz because the subharmonic signal plateaus from 75–
125 mmHg. In addition, transmit frequencies 1.7–5.0 MHz
involved extracting the subharmonic signal outside the band-
width of the transducers used in this study. Future use of
a transducer with a bandwidth that includes both the sub-
harmonic and transmit frequencies may thus further increase
upon the sensitivities found in this study. The ascending and
descending pattern of the subharmonic-pressure relationship,
nonetheless, are unique characteristics of SonoVue bubble
behavior, and are independent of the choice of transducer.
B. The subharmonic-pressure response of SonoVue differs
from other microbubble ultrasound contrast agents
The observed increase in the subharmonic signal of
SonoVue from 0–75 mmHg hydrostatic pressure was in stark
contrast to our hypothesis predicting a linear decrease from
0–200 mmHg. Our hypothesis was based upon previous work
that found this linear decrease in subharmonic signal across
multiple ultrasound contrast agents — Sonazoid, Optison,
Levovist and Definity — but SonoVue was not investigated
in that study [10]. In agreement with our findings, Li and
colleagues have recently reported an increase in the subhar-
monic amplitude of SonoVue from 0–50 mmHg hydrostatic
pressure, followed by a decrease from 50–180 mmHg, at
transmit frequency 4 MHz and peak-negative acoustic pressure
350 kPa [17]. At 450 kPa peak-negative acoustic pressure and
even higher mechanical indices (≥0.225), however, Li and
colleagues observed a decrease in the subharmonic amplitude
of SonoVue with hydrostatic pressure [17]. This may be due
to microbubble destruction at higher mechanical indices, and
thus demonstrates the need for low mechanical index imaging
in this new application of using SonoVue microbubbles to
estimate hydrostatic pressure. A direct comparison of the
subharmonic response of SonoVue with other microbubble ul-
trasound contrast agents will help verify this different behavior
of SonoVue [31].
C. Decreasing surface tension may underpin the ascending
phase of the SonoVue subharmonic-pressure relationship
Our simulations using the Rayleigh-Plesset equation re-
vealed an increase in the subharmonic signal with decreas-
ing bubble surface tension, and a decrease in the subhar-
monic signal with increasing hydrostatic pressure. These com-
peting effects of hydrostatic pressure and surface tension
likely underpin the resulting net subharmonic signal observed
experimentally from SonoVue microbubbles. Based on our
simulation results, we speculate that the observed increase
in the subharmonic signal of SonoVue from 0–75 mmHg
pressure was driven by a decreasing microbubble surface
tension (Fig. 7). With decreasing surface tension, the oscil-
lations of microbubbles shift toward more compression than
expansion [11]. In addition to SonoVue microbubbles, which
consist of sulfur hexafluoride gas (SF6) in a phospholipid
shell, this “compression-only” behavior has been implicated in
the increased subharmonic signal of experimental perfluorobu-
tane (C4F10) phospholipid-shell microbubbles with hydrostatic
pressure [11].
D. Microbubble buckling and destruction contribute to the
descending phase of the SonoVue subharmonic-pressure re-
lationship
Above 125 mmHg hydrostatic pressure, we speculate that
most of the SonoVue microbubbles are in a buckled state
(i.e., zero surface tension), and thus the subharmonic signal
of SonoVue decreases with increasing hydrostatic pressure
(Fig. 7) [19]. The extent of the decrease of the subharmonic
signal observed experimentally, however, was greater than
that predicted by our simulations using the Rayleigh-Plesset
equation. This discrepancy may be explained by irreversible
bubble destruction at 150–200 mmHg pressures, which would
violate the assumption that changes in void fraction solely
reflect changes in bubble volume (v) — and not fewer bubbles
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per unit volume (cf., Equation 2; vgasvgas reference =
pref
p0
). Indeed,
the lower subharmonic signal observed in the hysteresis ex-
periments following exposure to 150–200 mmHg pressures for
1 min, but not following exposure to 0–125 mmHg, support
the inference of microbubble destruction above 125 mmHg.
Destruction of SonoVue microbubbles upon exposure to higher
hydrostatic pressures may include lipid shedding from the
bubble shell and static diffusion of SF6 gas out of the bubble
core, followed by inertial cavitation and fragmentation of the
bubble when the pressure is released [32]–[34].
Taken together, the descending phase of the subharmonic-
pressure relationship of SonoVue from 125–200 mmHg is
likely underpinned by both bubble buckling and bubble de-
struction. Our findings additionally reiterate the importance
of empirical data in investigations of microbubble ultrasound
contrast agents, as existing mathematical models do not yet
fully characterize complex microbubble mechanics [12], [35].
E. Clinical implications
The subharmonic-pressure relationship of SonoVue may
be used to estimate pressures in vivo. Whilst systolic and
diastolic brachial artery pressures are measured routinely using
a sphygmomanometer, blood pressures in the heart and aorta
are currently assessed invasively using a pressure catheter. The
linear increase in subharmonic amplitude from 0–75 mmHg
may be applied to estimate left ventricular diastolic pres-
sures (4-12 mmHg), which are critical for the assessment
of diastolic performance [8], [9]. This pressure range is also
appropriate for the assessment of right ventricular pressure (2–
30 mmHg), and left (4–12 mmHg) and right atrial pressures
(2–6 mmHg) across the cardiac cycle. On the other hand, the
linear decrease in the subharmonic signal above 75 mmHg
may be applied to assess aortic pressures across the cardiac
cycle (80–120 mmHg). For clinical applications, an estimate
of pressure within 5 mmHg of reference pressure is ideal
[36], and appear to be most likely achievable with SonoVue
at transmit frequencies 2.1, 4.0 and 5.0 MHz.
One possible obstacle in translating our ultrasound transmit
and receive configurations to image the heart and great vessels
could be a greater attenuation through the body than through
the static pressure phantom in this study. However, the attenu-
ation through 1 cm of septal or lateral myocardium at transmit
frequency 2.1 MHz is less than 3 dB [37], [38], which is less
than the measured 4.6–16.2 dB signal loss in our phantom.
It is thus likely that the transmit and receive configurations
developed in this study can be successfully translated to in
vivo imaging. In addition, the transducers used in this study
are already routinely used for cardiac and vascular imaging.
In addition to SonoVue, other microbubble ultrasound con-
trast agents such as Sonazoid and Definity have been investi-
gated as potential pressure sensors. These have shown potential
as non-invasive pressure sensors in the right ventricle [5],
for diagnosing portal hypertension [39], and for estimating
tumor interstitial fluid pressure in breast cancer [40]. One
disadvantage of using SonoVue, compared with Sonazoid or
Definity, is its non-unique subharmonic amplitudes from 0–
200 mmHg hydrostatic pressures. However, an advantage of
SonoVue is its greater sensitivity to changes in pressure, as
sensitivities of up to ±0.16 dB/mmHg were found in this
study. An earlier study by Halldorsdottir and colleagues com-
paring different microbubble ultrasound agents found lower
sensitivities for Sonazoid (−0.08 dB/mmHg), Definity (−0.07
dB/mmHg) and Optison (−0.06 dB/mmHg), but did not in-
vestigate SonoVue [10]. Optimization of the ultrasound pulse
shape subsequently improved the sensitivity of Sonazoid to
−0.17 dB/mmHg for 0–40 mmHg hydrostatic pressures, but
the maximum pressure range was limited by the decrease of
the subharmonic signal below the noise floor [41]. Despite
extensive research on Sonazoid, one of its limitations is that
it is currently not approved for use in Europe [15]. The
investigation of SonoVue, which is widely used in Europe,
may help accelerate this exciting new technology from the lab
to the clinic in Europe. Altogether, these characteristics need
to be considered and balanced to ultimately choose the best
possible microbubble ultrasound contrast agent for the target
application in the human body.
F. Limitations and future work
This work included the development of a new static pressure
phantom, suitable for microbubble experiments [20]. As the
probe and cell culture cassette were positioned manually
without the use of a rotation mount, the angle of incidence
may not have been precisely 45◦. Manual measurement with
a protractor, however, allowed us to estimate the angle of
incidence and with this, calculate a best-estimate of the signal
loss prior to the pressure chamber. Due to resource limitations,
our pressure meter was calibrated with a simple 2 m water
column and only reached 147 mmHg hydrostatic pressure. To
achieve a higher accuracy of pressures above 147 mmHg on
the pressure meter, a pneumatic calibrator may be used in the
future. In addition, only two sets of data were acquired at each
hydrostatic pressure level and more sets would have been ideal.
However, this was the result of a balance between minimizing
the duration of experiments from the point of microbubble
reconstitution (to minimize differences in microbubble prop-
erties over time), and maximizing the number of hydrostatic
pressure levels (n = 9) and acoustic outputs investigated
(n = 20). A visual inspection of the first two sets of data
to determine any crossover of the datapoints was used instead
to exclude erroneous datasets and to ensure the best estimate
of the subharmonic amplitude of SonoVue in this study.
To provide first insights into the mechanisms underlying
the subharmonic-pressure relationship of SonoVue, we used
a model of a pure gas bubble with an effective surface ten-
sion [19], coupled with a simple representation of the bubble
cloud response. This provided qualitative insight into our
experimental findings, but does not fully represent the complex
interaction between bubble clusters and acoustic waves [35].
Further work using more comprehensive and elaborate models,
such as the subgrid model for bubbly cavitating flows proposed
by Fuster and Colonius [42], will enable a better representation
of the bubble cloud beyond commonly used single bubble
models [12].
Building upon the ultrasound acquisition protocol and signal
processing toolbox developed in this study, future work will
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include shortening the protocol to be able to complete this
test within 20 min in the clinic (the experimental protocol
in this study investigating 0–200 mmHg hydrostatic pressures
at one transmit frequency took up to 4.5 h to complete).
This will likely include quicker identification of the optimal
acoustic output and subsequent data collection across time
at this single acoustic output [26], [43]. As differences in
attenuation, blood viscosity [44] and temperature [45] likely
affect the subharmonic signal of SonoVue, we envision that
an incremental acoustic output scan will be necessary for
each patient acquisition to identify an individualized optimal
acoustic output, similar to previous work on Sonazoid [26]
and Definity [5]. Studies conducted in vitro have found that
an increase in temperature from room temperature to body
temperature decreases microbubble stability [45], while an in-
crease in viscosity from water to blood has the opposite effect
of increasing microbubble stability [44]. Future experiments
at body temperature and in a blood-mimicking fluid medium
(instead of at room temperature and in water in this study)
will therefore enable optimization of this technique prior to
in vivo testing. In addition, amplitude modulation and pulse-
shaping may be investigated as methods to further enhance the
subharmonic signal of SonoVue [41], [46].
V. CONCLUSION
The subharmonic signal of SonoVue first increased with
hydrostatic pressure across all experimental conditions (0–
50 mmHg), and then decreased (125–200 mmHg). The in-
crease in the subharmonic signal of SonoVue may be driven
by a decreasing bubble surface tension, while the decrease
may be attributed to both shell buckling and bubble destruc-
tion. Results report the largest sensitivity to date across 0–
200 mmHg (±0.16 dB/mmHg), opening promising transla-
tional perspectives for a less invasive method to assess diastolic
filling pressures (compared with inserting a catheter into the
heart).
APPENDIX
CHARACTERIZATION OF THE INSERTION LOSS THROUGH
ONE WINDOW OF THE CLINICELL CHAMBER
Table V shows the insertion loss through one window of the
CLINIcell chamber at 0–50◦ angles of insonation, across 1–
7 MHz transmit frequencies. Future ultrasound studies using
the CLINIcell cell culture cassette with 175 µm membrane
can use this detailed characterization to calculate the acoustic
signal loss in their experimental setups.
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